Adrenocortical Carcinoma Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Adrenocortical Carcinoma Treatment Market size is projected to reach USD 595.6 million by 2028, from USD 545.6 million in 2020, at a CAGR of 6% during the forecast period 2022-2028.

Adrenocortical Carcinoma is a rare cancer that affects the outer layer of the adrenal gland, which is responsible for producing certain hormones and maintaining optimal blood pressure levels. Adrenal cortical cancer is relatively common in children compared to other cancers, but it can also affect adults. The most common symptoms of adrenocortical cancer are abdominal pain, high blood pressure, weight gain, and frequent urination, which are usually caused by tumors that secrete excess hormones from the adrenal glands. Mitotan is the only drug approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMEA) for the treatment of metastatic adrenocortical cancer.

Market Segments

Adrenocortical Carcinoma Treatment Market, by Type

• Localized Adrenocortical Carcinoma
• Metastatic Adrenocortical Carcinoma

Adrenocortical Carcinoma Treatment Market, by Therapy

• Surgery
• Laparoscopic surgery
• Open surgery
• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• External beam radiation therapy
• Brachytherapy
• Adjuvant Therapy

Key Players

Arqule, Pfizer Ltd., EnGeneIC Ltd, Exelixis, Inc., Millendo Therapeutics, Inc., Merck & Co., Orphagen Pharmaceuticals, Inc., HRA Pharma, Bristol-Myers Squibb Company, General Electric Company, WG Critical Care, LLC, Mylan N.V., Fresenius Kabi AG, Sinovision Technologies (Beijing) CO., Ltd., Hitachi, Ltd., NeuroLogica Corp., and Digirad Corporation are some of the key players in the global adrenocortical carcinoma treatment market.

Scope of the Report

The research study analyzes the global Adrenocortical Carcinoma Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Adrenocortical Carcinoma Treatment Market Report

1. What was the Adrenocortical Carcinoma Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Adrenocortical Carcinoma Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Adrenocortical Carcinoma Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.